DKSHマーケットエクスパンションサービスジャパン テクノロジー事業部門 Official site

SOTAX Corporation BioJECT Cell

"We will exhibit at the Pharma Lab EXPO Tokyo" - New solution for subcutaneous injection drug release testing - BioJECT Cell

We are pleased to announce that SOTAX, in close collaboration with the National University of Singapore, has developed a new BioJECT cell (patent pending) compatible with the CE7smart (SOTAX JP3 (USP4) flow-through cell dissolution testing device) as a new solution for in vitro testing of subcutaneous injection drugs such as insulin. This cell features a small container called a biomatrix for filling samples, allowing for testing that simulates subcutaneous tissue. By combining the BioJECT cell with the CE7smart, we support the development of effective testing methods for various subcutaneous injection drugs, including in-situ implants, peptides, and low molecular weight compounds. ■ Exhibition Name: 7th Pharma Lab EXPO Tokyo ■ Dates: July 9 (Wed) - 11 (Fri), 2025 ■ Time: 10:00 AM - 5:00 PM ■ Venue: Tokyo Big Sight ■ Booth Number: E6-26

SOTAX company's product page

basic information

- Compliant with JP3 (USP4) standards - Supports 6 samples - Hydrodynamic properties have been demonstrated - Evaluation possible without using membranes that are difficult to characterize and are susceptible to batch variation - Easy adjustment of the gel used, allowing for increased selectivity of release with compound addition

Price information

Please contact us.

Delivery Time

Model number/Brand name

BioJECT Cell

Applications/Examples of results

Pharmaceutical and chemical industry

Sotax Fully Automatic Dissolution Testing Machine DT50 Catalog

PRODUCT

SOTAX Comprehensive Catalog

CATALOG

News about this product(2)

Recommended products

Distributors